SENSODETECT Stock Swiss Exchange
Equities
SE0003037456
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- SEK | - |
05-27 | SensoDetect Aktiebolag Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-27 | SensoDetect AB Appoints Saleh and Löfström to Medicinal Advisory Board | CI |
Sales 2021 | 2.58M 245K 334K | Sales 2022 | 820K 77.91K 106K | Capitalization | 36.86M 3.5M 4.77M |
---|---|---|---|---|---|
Net income 2021 | -7M -665K -907K | Net income 2022 | -8M -760K -1.04M | EV / Sales 2021 | 20.2 x |
Net cash position 2021 | 1.89M 180K 245K | Net cash position 2022 | 660K 62.71K 85.47K | EV / Sales 2022 | 44.1 x |
P/E ratio 2021 |
-6.73
x | P/E ratio 2022 |
-4.07
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99% |
Managers | Title | Age | Since |
---|---|---|---|
Per Anders Hedin
CEO | Chief Executive Officer | - | - |
Gunnar Telhammar
DFI | Director of Finance/CFO | 63 | - |
Wendi Ma
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 65 | - | |
Chairman | 57 | - | |
Haqvin Svensson
BRD | Director/Board Member | - | 19-05-01 |
1st Jan change | Capi. | |
---|---|---|
-27.52% | 16.33B | |
-40.04% | 2.96B | |
+15.16% | 1.82B | |
-6.86% | 1.55B | |
+38.67% | 1.41B | |
-15.36% | 976M | |
-26.08% | 846M | |
+3.53% | 811M | |
-24.63% | 631M |